Avicanna Inc. (AVCNF)
OTCMKTS · Delayed Price · Currency is USD
0.1340
+0.0010 (0.75%)
Feb 11, 2026, 9:30 AM EST
Avicanna Revenue
Avicanna had revenue of 6.40M CAD in the quarter ending September 30, 2025, with 1.96% growth. This brings the company's revenue in the last twelve months to 25.50M, up 2.41% year-over-year. In the year 2024, Avicanna had annual revenue of 25.46M with 51.62% growth.
Revenue (ttm)
25.50M CAD
Revenue Growth
+2.41%
P/S Ratio
0.83
Revenue / Employee
293.05K CAD
Employees
87
Market Cap
15.23M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.46M | 8.67M | 51.62% |
| Dec 31, 2023 | 16.79M | 12.74M | 314.82% |
| Dec 31, 2022 | 4.05M | 778.98K | 23.83% |
| Dec 31, 2021 | 3.27M | 1.70M | 108.20% |
| Dec 31, 2020 | 1.57M | 1.40M | 833.16% |
| Dec 31, 2019 | 168.25K | 50.28K | 42.62% |
| Dec 31, 2018 | 117.97K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Cannabist Company Holdings | 349.84M |
| MariMed | 157.38M |
| CV Sciences | 14.37M |
| CordovaCann | 10.20M |
| Tristar Wellness Solutions | 4.00M |
| Healthy Extracts | 3.59M |
| Kaya Holdings | 26.69K |
Avicanna News
- 13 days ago - Avicanna Announces Medical Cannabis Real World Evidence Results and Publication - GlobeNewsWire
- 7 weeks ago - Avicanna Announces Changes to its Board of Directors - GlobeNewsWire
- 7 weeks ago - Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update - GlobeNewsWire
- 2 months ago - Avicanna Inc. (AVCN:CA) Discusses Strategic Pivot, Business Pillars, and Pharmaceutical Pipeline Progress Transcript - Seeking Alpha
- 3 months ago - Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform - GlobeNewsWire
- 3 months ago - Avicanna Reports Q3 2025 - GlobeNewsWire
- 5 months ago - Avicanna Announces Change in CFO - GlobeNewsWire
- 5 months ago - Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland - GlobeNewsWire